VSTM logo

VSTM
Verastem Inc

24,075
Mkt Cap
$619.01M
Volume
2.46M
52W High
$11.25
52W Low
$3.46
PE Ratio
-2.30
VSTM Fundamentals
Price
$9.81
Prev Close
$9.27
Open
$9.60
50D MA
$8.82
Beta
1.46
Avg. Volume
2.24M
EPS (Annual)
-$3.66
P/B
-42.18
Rev/Employee
$128,205.13
Loading...
Loading...
News
all
press releases
Verastem (NASDAQ:VSTM) Shares Up 9.4% - Should You Buy?
Verastem (NASDAQ:VSTM) Trading Up 9.4% - Time to Buy...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Verastem (NASDAQ:VSTM) Shares Down 5.7% - Should You Sell?
Verastem (NASDAQ:VSTM) Stock Price Down 5.7% - Should You Sell...
MarketBeat·5d ago
News Placeholder
TEM Continues to Strengthen Its Genomics Leadership With New Products
Tempus AI advances its genomics push with new assays, CDx progress and plans for whole-genome sequencing to drive future growth.
Zacks·7d ago
News Placeholder
Verastem Oncology Announces Pricing of $90 Million Public Offering of Common Stock and Pre-Funded Warrants
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the pricing of its previously...
Business Wire·7d ago
News Placeholder
Verastem Oncology Announces Proposed Public Offering of Common Stock
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that it intends to offer and sell...
Business Wire·7d ago
News Placeholder
HC Wainwright Brokers Lower Earnings Estimates for Verastem
Verastem, Inc. (NASDAQ:VSTM - Free Report) - Research analysts at HC Wainwright cut their FY2025 earnings per share (EPS) estimates for shares of Verastem in a research note issued on Wednesday...
MarketBeat·11d ago
News Placeholder
Verastem (NASDAQ:VSTM) Downgraded by Wall Street Zen to Sell
Wall Street Zen cut shares of Verastem from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·13d ago
News Placeholder
Verastem (NASDAQ:VSTM) CEO Dan Paterson Sells 3,299 Shares
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) CEO Dan Paterson sold 3,299 shares of the firm's stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $9.74...
MarketBeat·13d ago
News Placeholder
Verastem (NASDAQ:VSTM) CEO Sells $32,132.26 in Stock
Verastem, Inc. (NASDAQ:VSTM - Get Free Report) CEO Dan Paterson sold 3,299 shares of the business's stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $9.74...
MarketBeat·14d ago
News Placeholder
Verastem Oncology to Present at Upcoming Investor Conferences
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is...
Business Wire·16d ago

Latest VSTM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.